Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China · Delayed Price · Currency is CNY
11.98
-0.19 (-1.56%)
Feb 13, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Technical Service
201.21M
16.55M---
Other
17.86M
7.65M10.50M--
Other Growth
-
-27.15%---
Autonomous Vaccine
2.54B
5.04B3.43B--
Autonomous Vaccine Growth
-
46.86%---
Intermediate Products
60.26M
27.16M23.88M--
Intermediate Products Growth
-
13.76%---
Production Division
-
--2.95B1.13B
Production Division Growth
-
--162.16%29.98%
Research and Development (R&D) Division
-
--131.45M8.29M
Research and Development (R&D) Division Growth
-
--1485.09%-80.12%
Offset of Business Segment
-
---145.47M-13.52M
Technical Services
-
-45.28K--
Total
2.82B
5.09B3.46B2.94B1.12B
Total Growth
-
46.89%17.82%162.13%27.55%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Northeast China
252.42M
567.36M365.48M468.11M103.55M
Northeast China Growth
-
55.24%-21.93%352.06%42.29%
Eastern China
874.69M
1.71B1.31B842.60M353.34M
Eastern China Growth
-
30.69%55.26%138.47%21.72%
South China Region
404.62M
838.37M518.34M427.54M202.53M
South China Region Growth
-
61.74%21.24%111.10%29.36%
Central China Region
332.25M
771.53M637.01M713.32M171.86M
Central China Region Growth
-
21.12%-10.70%315.05%31.09%
Southwest Northwest Region
387.18M
916.10M567.95M530.09M207.24M
Southwest Northwest Region Growth
-
61.30%7.14%155.79%4.26%
Overseas Region
570.29M
283.41M65.87M102.83M96.21M
Overseas Region Growth
-
330.25%-35.94%6.88%63.60%
Intersegment Offset
-
---145.47M-13.52M
Total
2.82B
5.09B3.46B2.94B1.12B
Total Growth
-
46.89%17.82%162.13%27.55%
Source: S&P Global Market Intelligence.